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Abstract
A posterior segment approach for cell transplantation or injection into the subretinal space of the dog has
been developed. Controlled penetration to the subretinal space was achieved using a 29-gauge injection
cannula, either blunted or with a 30° sharpened bevel, and partially ensheathed with moveable plastic tubing.
Depending on the injection volume used, the retina detached, and the fluid was reabsorbed within 1–3 weeks,
although for smaller volumes the retina reattached within a matter of days. The optimal injection volume used
was between 100 and 150 μl, or two injections of 55 μl each. By ophthalmoscopy following the surgery, it was
possible to serially monitor the injection site and retinal bleb through fundus photography. Light microscopy
demonstrates the distribution of stable, viable RPE cells in the subretinal space up to 6 months. The
transplantation technique developed for the dog is atraumatic and free from any major surgical or clinical
complications. It can be readily used to deliver cells or fluids to localized regions of the subretinal space.
Keywords
animal model, dog, posterior segment, retinal pigment epithelial transplantation, subretinal injection, retinitis
pigmentosa
Disciplines
Medicine and Health Sciences | Ophthalmology | Veterinary Medicine
Author(s)
Maria E. Verdugo, Julie Alling, Eliot Lazar, Manuel del Cerro, Jharna Ray, and Gustavo D. Aguirre
This journal article is available at ScholarlyCommons: https://repository.upenn.edu/vet_papers/25
Cell Transplantation, Vol. 10, pp. 317–327, 2001 0963-6897/01 $20.00 + .00
Printed in the USA. All rights reserved. Copyright  2001 Cognizant Comm. Corp.
www.cognizantcommunication.com
Posterior Segment Approach for Subretinal Transplantation
or Injection in the Canine Model
Maria E. Verdugo,* Julie Alling,* Eliot S. Lazar,† Manuel del Cerro,†‡ Jharna Ray,*
and Gustavo Aguirre*
*James A. Baker Institute for Animal Health, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853
Departments of †Ophthalmology and ‡Neurobiology and Anatomy, University of Rochester School of Medicine,
Rochester, NY 14642
A posterior segment approach for cell transplantation or injection into the subretinal space of the dog has
been developed. Controlled penetration to the subretinal space was achieved using a 29-gauge injection
cannula, either blunted or with a 30° sharpened bevel, and partially ensheathed with moveable plastic tubing.
Depending on the injection volume used, the retina detached, and the fluid was reabsorbed within 1–3
weeks, although for smaller volumes the retina reattached within a matter of days. The optimal injection
volume used was between 100 and 150 µl, or two injections of 55 µl each. By ophthalmoscopy following
the surgery, it was possible to serially monitor the injection site and retinal bleb through fundus photography.
Light microscopy demonstrates the distribution of stable, viable RPE cells in the subretinal space up to 6
months. The transplantation technique developed for the dog is atraumatic and free from any major surgical
or clinical complications. It can be readily used to deliver cells or fluids to localized regions of the subretinal
space.
Key words: Animal model; Dog; Posterior segment; Retinal pigment epithelial transplantation; Subretinal
injection; Retinitis pigmentosa
INTRODUCTION (19), monkey (10), and rabbit (12). Typicaly, these stud-
ies have involved delivering dissociated cell suspen-
Intraocular transplantation of reginal pigment epithe- sions, sheets, or patches of RPE into the subretinal
lial (RPE) cells provides the prospect of restoring nor- space.
mal function to this cell layer in individuals having pri- The transplantation studies in the experimental mod-
mary RPE dysfunction or degeneration, or where there els have, as their ultimate application, the use of similar
is a photoreceptor abnormality secondary to an RPE de- treatment strategies in human patients. Primary diseases
fect. It also can be used to transplant genetically modi- of the RPE in humans with secondary photoreceptor
fied cells to either replace the function of a mutant gene dysfunction or degeneration would be amenable to trans-
or to deliver trophic factors to the interphotoreceptor plantation of normal cells or direct in situ delivery of
space, which can promote the survival of diseased visual vectors to transfer the normal cDNA and correct the un-
cells. The general surgical techniques for injection or derlying genetic defect. Dysfunction of RPE cells has
transplantation into the subretinal space that are directed been implicated in many, frequently untreatable, retinal
towards the treatment of retinal degenerative diseases diseases including age-related macular degeneration.
have been undergoing constant evolution. During the Additionally, recently described mutations in genes ex-
last two decades, numerous investigators have trans- pressed exclusively in the RPE of humans and animals
planted RPE cells into the subretinal space of normal [e.g., RPE65 (1,23), cellular retinaldehyde binding pro-
eyes, as well as into the eyes of experimental animals tein (CRALBP) (24) and retinol dehydrogenase (27)]
with retinal degenerations (10,18,22). The RPE trans- make the specific treatment of this cell layer a therapeu-
plantation has been done in several animal models such tic imperative.
as rat (18), rabbit (21), monkey (10), and miniature pig Experimental studies have demonstrated that photore-
(14), including xenografting of human RPE cells into rat ceptor degeneration can be prevented or delayed in sev-
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eral ways. For example, transplantation of healthy RPE injection volumes ranged between 10 and 200 µl; these
volumes were well within the limits tolerated by the eyecells into the subretinal space of RCS rats with photore-
ceptor degeneration secondary to a primary RPE defect as the vitreous volume of the normal adult dog eye
ranges between 2.5 and 3.2 ml (4). Of the group receiv-resulted in the functional survival of the host photore-
ceptors (15,20). Similarly, intraocular injection of basic ing injections of cultured and dissociated cells, two dogs
had RPE autografts from cells collected from the fellowfibroblast growth factor or other cytokines delayed the
photoreceptor degeneration in dystrophic RCS rats, and enucleated eye and 10 received allografts (RPE cells or
choroidal fibroblasts) of cells obtained from various ca-rescued photoreceptors in the light-damage rat model
(8,16). Injection into the subretinal space of genetically nine donors; eight dogs received bilateral injections and
two received unilateral injections. Note that with the ex-modified cells to produce the desired trophic factors, re-
combinant viral vectors, or recombinant proteins could ception of one dog that received subretinal injection of
RPE cells in one eye and choroidal fibroblasts in theensure prolonged availability of the particular substance
lacking or deficient in the host photoreceptors or RPE other eye (Table 1, animal #7), all of the remaining dogs
had injections of RPE cells. No attempts were made tocells. Delivery of the appropriate factors to diseased vi-
sual cells may thus provide a therapeutic benefit in a tissue type the donors and recipients to optimize the
match and avoid potential host vs. graft reaction. Detailsvariety of currently untreatable diseases.
For surgical intervention of the subretinal space, of the experimental animals and protocols are summa-
rized in Table 1.three different approaches have been used previously:
anterior trans-vitreal (7,14,21,26), posterior trans-scleral
Donor Cell Harvest and Preparation of RPE(18,26), and open sky (10). Lazar and del Cerro (17) for Transplantationdeveloped a posterior injection technique in the rat that
is complication free, allows controlled penetration of the Eyes from normal dogs were obtained from other in-
vestigators at the end of their studies and were used assubretinal space, and the placement of the graft is di-
rectly visualized through the pupil. This approach ap- donors for the allografts. All eyes were collected in ice-
chilled Ca2+/Mg2+-free Puck’s saline F (0.127 M NaCl,peared of value for use in experimental animals such as
the dog because it reduced the need for expensive and 3.82 mM KCl, 1.261 mM Na2HPO4, 0.61 mM KH2PO4,
0.1 mM EDTA) containing antibiotics (penicillin, strep-extensive instrumentation required by the anterior ap-
proach and, as well, avoided potential traumatic injury tomycin, and gentamycin). For autologous transplanta-
tion surgery, RPE cells were harvested from one enucle-to the lens. In this study we report the modification of
the posterior segment approach for use in dogs to deliver ated eye, processed in the same manner as allograft
cells, and transplanted into the fellow eye. The RPEdissociated cells or soluble products to the subretinal
space. These modifications were required because in the cells from donors eyes (allograft or autograft) were har-
vested and cultured using the method of Ray et al. (25).dog the globe is placed deeply in the orbit, surgical ex-
posure is limited, and the sclera, conjunctiva, and peri- Cells were dissociated by repeated trypsinization, rinsed
twice with 15% fetal bovine serum (FBS; Atlanta Bio-ocular tunics are much thicker than in the rat.
logicals, Norcross, GA) containing Dulbecco’s modified
MATERIALS AND METHODS Eagle medium [DMEM, with high glucose (4500 mg/L):
Experimental Animals and Anesthesia L-glutamine, pyridoxine hydrochloride without sodium
pyruvate or sodium bicarbonate] (Life Technologies,A total of 15 healthy normal adult dogs, either bea-
Gaithersburg, MD), and plated at a seeding density ofgles or crossbred, were used in the studies. All experi-
2–3 × 105 cells/35-mm dish. Cells were grown inmental procedures adhered to the guidelines of the
DMEM containing 15% FBS, 2.5% glutamine, and 1%ARVO Resolution on Use of Animals in Ophthalmic
amphotericin B (Life Technologies) and maintained in aand Vision Research. The dogs were sedated by intra-
humidified atmosphere at 37°C in the presence of 95%muscular injection of acepromazine maleate (0.1 mg/kg)
air/5% CO2. At confluence cells were passaged (1:3 ra-administered with atropine sulfate (0.04 mg/kg), and an-
tio), and first passage cells (P1) were grown until theyesthetized by the intravenous injection of ketamine hy-
reached to approximately 70% confluency.drochloride (2 mg/kg) and diazepam (0.2 mg/kg). To
For transplantation, the 70% confluent P1 cells weremaintain anesthesia, the dogs were intubated and kept at
dissociated with 0.25% trypsin, washed two times witha surgical plane of anesthesia with halothane (1.5–
DMEM, and resuspended in DMEM for injection. Cell2.5%); the dose of halothane was adjusted depending
viability was determined using the trypan blue (Sigma,on the size of the dog, tidal volume, and frequency of
St. Louis, MO) exclusion test (5). Briefly, 10 µl of cellrespiration. Three dogs had bilateral subretinal injections
suspension was mixed with 40 µl of 0.4% trypan blue,of India ink and 12 dogs had subretinal injections of
cultured and dissociated cells. Depending on the study, kept at room temperature for 2–5 min, then a 12 µl ali-
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quot was placed in a Neubauer Hemocytometer slide
chamber and counted for the blue and the colorless cells.
Colorless cells, which excluded trypan blue, were indic-
ative of live cells, while blue cells were dead; in general,
the percentage of dead cells was between 7% and 8%.
The numbers of cells and subretinal volumes injected
are detailed in Table 1.
Delivery System and Transplantation Procedure
Prior to anesthesia and surgery, the pupils were
dilated with 1% tropicamide (Alcon Laboratories,
Fort Worth, TX), 1% atropine sulfate (Optopics Labora-
tories, Fairton, NJ), and 2.5% phenylephrine hydrochlo-
ride (Henry Schein, Florham Park, NJ). To obtain the
best possible visualization during surgery, the dog’s
head was fixed with a vacuum pack immobilizer and
positioned under a high-resolution operating micro-
scope. Throughout the surgery aseptic conditions were
followed.
The delivery system consisted of a custom made 29-
gauge cannula (Popper & Sons Inc., New Hyde Park,
NY), partially ensheathed with a tight plastic tubing, and
connected to a Kloehn microsyringe (Kloehn Ltd., Brea,
CA) by a 0.38-mm-diameter polyethylene tubing (Bec-
Figure 1. (A) Illustration of the delivery system used for su-ton Dickinson and Company, Sparks, MD), and a 29- bretinal injections. The 29-gauge cannula has a polyethylene
gauge blunt adapter needle (Kloehn Ltd., Brea, CA). For tubing sheath near the tip to control the depth of penetration.
injection volumes less than 50 µl, we used a 50-µl sy- A 0.38-mm-diameter polyethylene tube connects the cannula
to the injection syringe adapter (not shown). The beveled andringe; for greater volumes a 200-µl syringe was used.
blunt orientations of the cannula are shown. (B) Placement ofThe sheath used on the cannula was made from the same
the beveled point of the injection cannula in the subretinal0.38-mm polyethylene tubing, and exposed the 3–4 mm
space. Depth of penetration is controlled by the plastic sheath
of the tip, thus limiting the depth of penetration. The around the cannula, and the direction of fluid flow is illus-
length of the sheath was adjusted on the basis of the dog’s trated by the arrows.
age and estimated scleral thickness to allow the cannula
to reach subretinal space without penetrating the retina.
Such penetration could cause damage to the retina and transplantation site. The thin floor of the flap formed a
translucent membrane through which the choroid couldvitreous, forming holes or retinal tears that can leak
transplanted cells or injected fluids into the vitreous cav- be visualized. The blunt tipped or beveled cannula was
manually inserted through the floor of the scleral flapity. In the first seven surgeries, the 30° sharpened bev-
eled end of the cannula was used; in subsequent surger- and gently rotated in order to penetrate to the desired
depth, and then the injection was carried out. In general,ies, the rounded blunt end was used to avoid accidental
penetration of the retina. Figure 1 is a schematic repre- resistance to the needle penetration was present primar-
ily at the scleral surface and, to a much lesser extent, atsentation of the injection instruments and placement of
the cannula in the subretinal space. the RPE/Bruch’s membrane interface. Successful pene-
tration of this latter layer allowed the easy release ofTo expose the transplantation site, a Barraquer wire
eyelid retractor was used followed by a lateral cantho- the injection volume with gentle manual pressure of the
syringe plunger. Depending of the study, the volume in-tomy and a fornix-based conjunctival peritotomy. The
eye was rotated ventrally, exposing the superior rectus jected varied between 10 and 200 µl/injection site, and
there was minimal reflux if the injection rate was slow,muscle, and a 4-0 Dermalon suture (Davis-Geck, Dan-
bury, CT) was placed around the muscle for stabiliza- gradual, and volumes less than 150 µl were used. The
superior half of the eye was favored because in the dogtion. A focal conjunctival peritotomy was made 15–17
mm behind the corneo–scleral junction, and bleeding this area has a nonpigmented RPE overlying the reflec-
tive tapetum lucidum. As a result, it is easier to examinewas controlled by pinpoint cautery. A one third scleral
flap was dissected with a 45° K-Sharp knife (Katena and photograph the injection site(s). However, we have
done the same procedure in the inferior retinal quadrantsProducts Inc., Denville, NJ) to provide a window at the
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with no variation in the method or in the results (see centrations before processing for embedding in JB-4
(Sigma). The embedded retinal strips were sectioned atTable 1 for details).
Following the injection, the scleral flap was sutured 3 µm with tooled steel knives in an AO Spencer 820
Microtome; after flattening in a 68–80°F water bath, thewith nonabsorbable 6-0 Dermalon (Davis-Geck, Dan-
bury, CT) to identify the external site of injection once sections were transferred to a slide, heated (120°F for
5–10 min), and stained with methylene blue/Azure II.the eye was enucleated, and the canthotomy was closed
with 6-0 Dermalon nonabsorbable sutures in a simple The sections were mounted with Permount (Fisher Sci-
entific, Fair Lawn, NJ), coverslipped, and evaluated andinterrupted pattern. Immediately following surgery, 2
mg of triamcinolone acetonide (Kenalog-10; Bristol- photographed with a Zeiss Axioplan light microscope
(Zeiss, Inc., White Plains, NY).Myers Squibb Company, Princeton, NJ) was injected
subconjunctivally one time to prevent postoperative in-
RESULTSflammation. The postoperative treatment consisted of
Clinical Assessmentoral Clavamox (11 mg/kg), topical ophthalmic antibiotic/
steroid ointment and solution (neomycin, polymyxin B The injection procedure was well tolerated in the 12
sulfate, and dexamethasone, Altana Inc., Melville, NY), eyes that received subretinal cell injections. Postsurgical
administered 2 times a day for 1 week. Other topical observation periods ranged from 0 days to 24.5 weeks
medications (e.g., atropine sulfate 1%, gentamicin, or with a median survival time of 5 weeks (Table 1). Mild
prednisolone acetate 1%) were used in the postoperative conjunctivitis was noted in five eyes (three dogs), and a
period if there was ocular inflammation (atropine and small subconjunctival hemorrhage was present in one
prednisolone acetate) or if conjunctivitis was unrespon- eye of a different animal; these generally resolved
sive to the topical antibiotic/steroid medications used. within 1–2 weeks following surgery. Transient, low-
grade anterior uveitis and vitreal flare was found in four
Clinical Evaluations eyes (two dogs), and vitreal condensations or strands
were noted unilaterally in four other dogs. Cataracts didThe injection site was evaluated immediately after
not develop as a result of the surgical manipulation orsurgery using the operating microscope and a noncontact
injection.Super Field fundus lens (Volk, Mentor, OH). Following
Because most of the injections were made throughsurgical intervention, animals were routinely examined
the tapetum lucidum in the superior quadrant, the hall-at several points during the course of the study. In gen-
mark finding of the injection was the instantaneous focal
eral, dogs were examined during the first week, weekly–
color change in the tapetal layer as the result of penetra-biweekly for the first 4–6 weeks, and monthly thereaf-
tion of the injection cannula. This lesion appeared black,ter. In each case, the clinical exam included evaluation
presumably the result of a focal change in the cellular
of the anterior segment and a complete funduscopic ex-
organization of this layer, and this color change was evi-
amination using a Keeler binocular indirect ophthalmo- dent ophthalmoscopically regardless of whether the in-
scope (Keeler Instruments, Broomall, PA) and a Volk jection volume was media or cells (data not shown). The2.2 pan-retinal fundus lens. Direct ophthalmoscopy and
appearance of the fundus immediately following the in-biomicroscopy were used when necessary. Fundus pho- jection was dependent on the volume of fluid injected.tography was performed using Kodachrome 25 film Apart from the focal tapetal puncture wound, injection(Eastman Kodak Company, Rochester, NY) and a Kowa
volumes of 10 µl were not visible clinically. Small blebsRC-2 fundus camera (Kowa Company, Ltd., Japan) was
resulted from volumes of 50 µl, and these usually re-
used directly or indirectly through the Volk 2.2 or Nikon
sorbed in 2–3 days (Fig. 2). Medium-sized blebs re-20 diopter lenses.
sulted from injections of 100 µl, which resorbed within
1 week. Retinal folds were associated with the periph-Histological Procedures
eral border of small and medium-sized blebs, and these
The dogs were euthanatized with an overdose of so- flattened out with fluid resorption from the subretinal
dium pentobarbital administered intravenously, and the space. Larger injection volumes (e.g., 150 and 200 µl)
eyes were immediately enucleated and all adhering ex- resulted in very large blebs that occupied one quarter to
traocular muscles removed. The anterior segment was one half of the subretinal expanse and, in some cases,
removed with a single-edge razor blade that hemisected resulted in an increased intraocular pressure immedi-
the eye behind the lens, approximately 4–5 mm behind ately after injection.
the limbus. The eyecup was fixed with chilled 4% glu- The appearance of the injection site was dependent
taraldehyde in 0.1 M phosphate buffer (pH 7.4) for a on the number of RPE cells injected, their level of
minimum of 2–6 h, rinsed with the phosphate buffer, pigmentation, which is very variable in the dog, and
whether the cells were dispersed throughout the subreti-trimmed, and dehydrated through graded ethanol con-
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Table 1. Details of the Animals and Methods Used in the Subretinal Injection Studies
No. of Injections
Animal No./Eye Volume/Injection and Site Total No. RPE Cells/Eye Postinjection Period
India ink
#1/OD 10 µl 4 (2 sup./2 inf.) — 0 days
#1/OS 10 µl 4 (2 sup./2 inf.) — 0 days
#2/OD 10 µl 2 (sup.) — 0 days
#2/OS 10 µl 2 (sup.) 0 days
#3/OD 40 µl 2 (1 sup./1 inf.) — 0 days
#3/OS 40 µl 2 (1 sup./1 inf.) — 0 days
RPE autografts
#4/OS 10 µl 2 (1 sup./1 inf.) 4.5 × 105 5.1 weeks
#5/OD 55 µl 2 (sup.) 1 × 105 16 weeks
RPE (or CF) allografts
#6/OD 100 µl 1 (sup.) 1.4 × 105 0 days
#6/OS 200 µl 1 (sup.) 1.4 × 105 0 days
#7/OD 125 µl 2 (sup.) 1 × 106 3 weeks
#7/OS 125 µl 2 (sup.) 1 × 106(CF) 3 weeks
#8/OD 10 µl 2 (sup.) 3.8 × 105 3.2 weeks
#8/OS 10 µl 2 (sup.) 5.2 × 105 3.2 weeks
#9/OD 10 µl 2 (1 sup./1 inf.) 1.5 × 106 4 weeks
#9/OS 20 µl 2 (1 sup./1 inf.) 1.5 × 106 4 weeks
#10/OD 40 µl 2 (sup.) 4.6 × 106 5 weeks
#10/OS 50 µl 2 (sup.) 4.6 × 106 5 weeks
#11/OD 150 µl 1 (sup.) 1 × 106 5 weeks
#12/OD 10 µl 2 (1 sup./1 inf.) 6.5 × 105 6 weeks
#13/OD 15 µl 2 (1 sup./1 inf.) 9.5 × 105 7.1 weeks
#13/OS 15 µl 2 (1 sup./1 inf.) 9.5 × 105 7.1 weeks
$14/OD 40 µl 2 (1 sup./1 inf.) 5.6 × 105 21 weeks
#14/OS 50 µl 2 (1 sup./1 inf.) 5.4 × 105 21 weeks
#15/OD 25 µl 2 (1 sup./1 inf.) 5 × 105 24.5 weeks
#15/OS 25 µl 2 (1 sup./1 inf.) 5 × 105 24.5 weeks
OD: right eye; OS: left eye. sup.: superior quadrant; inf.: inferior quadrant. CF: choroidal fibroblasts.
nal bleb or were clustered at the site of injection. When postinjection period did not demonstrate changes in the
size or appearance of the transplant in animals that re-using low injection volumes and a high concentration of
RPE cells, the cells formed a darkly pigmented cluster ceived either autografts or allografts, and there was no
retinal or choroidal edema or inflammation, which couldin the subretinal space; larger volumes with similar con-
centration of cells dispersed the cells over a larger area have resulted from an immune-mediated response to the
transplanted cells.of the subretinal space and effectively eliminated the
cellular aggregates found with the lower volumes (Fig. In 5 of the 12 eyes, pigmented cells were found on
the retinal surface or posterior vitreous. In three of the2, compare A, B with C, D). Moreover, the presence of
hemorrhage, either subretinal (six eyes of five dogs) or eyes, the cells formed very small aggregates in the pos-
terior vitreal cortex or along strands of vitreous. In onevitreal (one eye), influenced the appearance of the injec-
tion site. In all cases, the blood was resorbed within 1–2 case, a focal cluster of RPE cells accumulated on the
retinal surface (Fig. 3). The presence of these cells onweeks and was never larger than the example illustrated
in Figure 2A. Serial examination of the eyes during the the retinal surface or vitreous indicated partial or full
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Figure 2. Fundus photographs of experimental animals at different postinjection intervals. (A, B) Dog #13 at 2 days (A) and 7.1
weeks (B) following injection of RPE cells (allograft) in a 15 µl volume. At the early time point there is a darkly pigmented
subretinal lesion resulting from the injection. Surrounding the transplanted cells is a zone of subretinal edema and hemorrhage
(arrows), which disappears by the 7.1 week time point without any alteration in the surrounding retina. (C, D) Dog #5 at 2 days
(C) and 2 weeks (D) following injection of autologous RPE cells in a 55 µl volume. Two injection sites are visible on the second
postoperative day, and these are located beneath a fluid bleb (C, small arrows). By 2 weeks the fluid has been resorbed and the
retina is flat.
retinal penetration by the injection cannula. Serial exam- Histologic Results
ination and photography of these eyes indicated that the In developing the surgical technique, we initially in-
small vitreal pigment cell clusters did not change in size jected India ink as a marker. Injections resulted in the
or extend into the retinal surface and/or vitreous in the separation of the retina from the pigment epithelium and
animals with postinjection survival periods of 3, 5, 21, the accumulation of injected fluid volume in the subreti-
and 24.5 weeks. In contrast, the one eye that received nal space. There was minimal damage to the retina adja-
allografts of choroidal fibroblasts (subretinal injection cent to the injection site (Fig. 4A, B). In the absence of
with secondary vitreal extension) showed by 3 weeks retinal penetration or reflux around the scleral puncture,
postinjection retinal traction that resulted from fibroblast the size of the subretinal bleb was dependent on the vol-
proliferation along the vitreal cortex and retinal surface ume of fluid injected. Similar results were obtained in
short-term injections of RPE cells suspended in DMEM(data not shown).
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Figure 3. Fundus photograph and photomicrograph of the right eye of dog #7, 3 weeks after the injection of RPE cells. (A)
Accidental penetration of the retina resulted in a preretinal cluster of pigmented cells (large open arrow) that obscures the underlying
retina and vessels; retinal folds (arrowheads) are at the margins of the pigment cell cluster. A smaller group of pigmented cells
(small arrows) is located over the posterior vitreous over two retinal vessels. (B) Histological section showing the cluster of RPE
cells attached to the inner retinal surface. Note that the pigment cells remain well circumscribed without extension into the retina
or vitreous (130×).
using larger fluid volumes. The separation of the retina but the injection cannula was withdrawn without injec-
from the RPE occurred at the tip of the photoreceptor tion, a focal retinal scar formed, often with limited fi-
outer segments, and caused minimal to no retinal dam- brous connective tissue that extended from the overlying
age either at the injection site or in adjacent areas (Fig. choroid (Fig. 7). The retina adjacent to these focal scars
5A, B). Because of the larger fluid volumes used, and was normal.
loss of cells during tissue processing, we could not iden-
DISCUSSIONtify the transplanted cells in the subretinal space.
This study demonstrates the development of a poste-With postinjection intervals of 3 weeks or longer,
rior approach for subretinal injection or cell transplanta-cells were readily identified in the subretinal space,
tion in the canine model. The procedure is atraumaticwhich had the cytologic characteristics of RPE and
and has minimal morbidity; long-term observation oflikely were of donor origin. Very rarely the cells formed
those animals that survived for nearly 6 months has indi-a partial monolayer located between the host RPE and
cated no major complications, either in the immediateretina (Fig. 6A). More frequently, single or isolated
postoperative period or later. This procedure is poten-clusters of RPE cells were found subretinally in the
tially adaptable for use in other large animal modelspreviously detached regions; again, these cells were in-
(e.g., primates and cats), which are commonly used interposed between the host RPE cells and the photorecep-
ophthalmic research studies.tors (Fig. 6B, C). Because cell marking studies were not
Studies requiring access to the subretinal space havecarried out, it was not possible to determine if the trans-
used either anterior or posterior approaches. The anteriorplanted cells replaced the host RPE cells on Bruch’s
approach is favored by surgeons working with nonro-membrane. In parallel with the clinical observations, we
dent eyes, because direct visualization of the placementdid not find vasculitis of the preretinal vessels nor cellu-
of the injection cannula in the subretinal space allowslar infiltration of mononuclear cells in the choroid, either
for greater success in placing the transplanted cellsat the transplant site or elsewhere, that could represent
(3,6,21). In addition to the greater need for surgical in-a rejection response to the transplant. The two eyes re-
strumentation and dexterity, the major limitations of theceiving RPE autografts showed the same response as
anterior approach include damage to the photoreceptorsthose that received allografts.
and nerve fiber layer and the presence of a retinal holeThe most common surgical complication was pene-
that can leak RPE cells into the vitreous where theytration of the retina by the injection cannula. At these
might eventually support proliferative vitreoretinopathy.sites the transplanted RPE cells formed cellular aggre-
The posterior or transcleral approach has been success-gates attached to the retinal surface (Fig. 3B). These cell
fully used in RPE transplantation studies to preventclusters remained aggregated and did not extend into the
adjacent retina. In cases where the retina was penetrated, photoreceptor degeneration in RCS rats (18,19). Wong-
324 VERDUGO ET AL.
Figure 4. Photomicrographs of an eye immediately following
the subretinal injection of 10 µl of India ink. (A) The fluid (*)
is confined to the subretinal space with a gradual elevation of
the retina. (B) The edge of the subretinal bleb shows the mini-
mal damage that has occurred away from the injection site.
The India ink is confined to the subretinal space, and the vitre-
ous (V) is free of injection product. (A = 250×).
pichedchai et al. (26) compared results of RPE trans- Figure 5. Photomicrographs of an eye immediately following
the injection of 100 µl of RPE cells in DMEM. (A) The fluidplantation in rabbits using the internal and external ap-
(*) has separated the retina from the RPE, but no transplantedproaches and found that the external approach resulted
RPE cells are visible at the edge of the subretinal bleb. (B)in better grafts, although the lack of direct visualization Away from the detachment site, the retina is intact. V, vitreous
was a limitation. cavity; PR, photoreceptor layer; ONL, outer nuclear layer;
Lazar and del Cerro (17) have developed a precise INL, inner nuclear layer. (A = 250×; B = 500×).
means of accessing the subretinal space of rats for trans-
plantation or injection. Their method is based on the
principle of using a preset stop to limit penetration of We have modified this technique for use in a larger
species such as the dog, and have found it to providethe needle, and direct visual control through the dilated
pupil of the host eye. The eye is maintained in the pri- consistent results once the technique is mastered. How-
ever, the lack of direct visualization during the injectionmary gaze position, and, because of the optical proper-
ties of the rat eye, one can directly monitor the penetra- procedure is a major limitation. Unlike the rodent,
whose readily mobile and anteriorly placed eye allowstion of the needle into the subretinal space and the
formation of the bleb through the operating microscope. access to the posterior sclera, the dog eye is large and
deeply set in the orbit. In order to access the posteriorSuch a method has the added advantage of allowing
real-time photography or video to document the trans- surface of the globe for injections, the eye must be ro-
tated away from the site of injection. Thus, the injectionsplantation procedure.
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Figure 6. Photomicrographs of dogs following subretinal injection of RPE cells, which survived for periods of 3 weeks or longer.
(A) Monolayer of transplanted cells (arrows) is present in the subretinal space (*) between the host RPE and the retina. The normal
photoreceptor integrity indicates that the separation of the retina is a processing artifact. (B, C) Transplanted RPE cells (white
arrows) located in the subretinal space adjacent to the host RPE. (A = 250×; B, C = 400×).
to limit the depth of needle penetration. Subsequent sur-
geries used the blunt end of the injection cannula for
tissue penetration, and, together with the plastic sheath
near the tip of the injection cannula, this prevented the
puncture of the retina as the needle entered the subreti-
nal space.
Even when the retina is penetrated and RPE cells
gained access to the vitreous cavity, we found no cellu-
lar proliferation or secondary complications in the ani-
mals. Although labeling to identify cell division was not
used, the RPE cell cluster that formed immediately after
the injection remained stable in size, did not extend into
the adjacent retina or vitreous cortex, and did not show
any evidence of proliferative activity and retinal trac-
tion, such as was produced when autologous choroidal
fibroblasts were used. This situation appears quite dif-
ferent from the human, where vitreal RPE proliferation
results in retinal membranes and proliferative vitreoreti-
Figure 7. Photomicrograph illustrating a focal retinal scar fol- nopathy (11,13). One possible difference is that we usedlowing penetration by the injection cannula. Connective tissue
normal eyes from healthy young adult animals for theseextends from the choroid and fills the retinal defect (250×).
studies, and there was no evidence of concurrent retinal
or vitreal disease prior to the injection or transplantation
procedure. In contrast, proliferative vitreoretinopathyare made by “feel” (i.e., sensing the resistance to the
develops in older human eyes that have abnormalities ofneedle penetration as it goes first through the base of the
the vitreous, retinal detachment, or other retinal surger-scieral flap and subsequently through Bruch’s mem-
ies and, as a result, may be predisposed for this devastat-brane). The lack of direct observation resulted in the
ing complication (9,13).puncture of the retina in the initial surgeries even when
the plastic sheath around the injection cannula was set We have used a large range of injection volumes with
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or without RPE cells. A volume of 10 µl resulted in a located in the subretinal space or accidentally injected
into the vitreous cavity, there was no evidence of im-nondetectable retinal bleb that covered a minimal retinal
expanse. Volumes of 150–200 µl were much more ef- mune rejection of RPE cells. Neither was there evidence
of retinal perivasculitis, edema, or cellular infiltration,fective in spreading through the subretinal space but, es-
pecially for injections of 200 µl, resulted in transient either at the transplantation site or further away. This
lack of response to RPE allografts was similar to whatincreases in intraocular pressure. If such large volumes
are required, then decompression of the globe by ante- was observed in the two RPE autographs. Because no
effort was made to tissue type the donor and host torior chamber paracentesis could be readily performed
following the subretinal injection. From these results, we maximize tissue compatibility, it is possible that the lack
of response could indicate that in the dog model theestimate that a volume of 50–75 µl injected into the
subretinal space in each of four quadrants (supero nasal transplant sites were immunologically privileged.
and temporal; infero nasal and temporal) would be re- ACKNOWLEDGMENTS: This work was supported by NEI/
quired to distribute the fluid over most of the subretinal NIH grants EY11142, 13132, and 06855, and the Foundation
Fighting Blindness. The authors are grateful to Sue Pearch-expanse. Such a volume would likely result in a com-
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